Turtlemint IPO: Slow Demand, Profitability Concerns

🔥 Main Takeaway

Turtlemint’s IPO is currently facing lukewarm investor interest, with subscription rates lagging and its Grey Market Premium declining, signaling concerns over its valuation and path to profitability.

📌 What Happened?

The Turtlemint IPO, an insurtech offering valued at over ₹4,500 crore, opened for public subscription on June 19 and is set to close on June 23, 2026.

By day two, the issue saw only 47% subscription. While Qualified Institutional Buyers (QIBs) showed 73% interest, retail investors subscribed 40% and non-institutional investors (NIIs) a mere 2%.

Ahead of the public launch, Turtlemint secured ₹397.20 crore from 32 anchor investors on June 18, allotting 2.61 crore equity shares at ₹152 each. Notable participants included ICICI Prudential Mutual Fund, Mirae Asset Mutual Fund, and BNP Paribas Financial Markets.

The Grey Market Premium (GMP) has significantly dropped from a peak of ₹6, now standing at +1.5. This suggests an estimated listing price of ₹153.5 per share, a marginal 0.99% premium over the IPO price of ₹152.

💰 Why It Matters

This slow subscription and declining GMP indicate investor caution, primarily driven by concerns around Turtlemint’s financial health and aggressive valuation.

Despite operating a technology-driven platform with over 5 lakh advisors and selling 1.6 crore policies, the company reported continued losses and a negative return on net worth of 47.29%.

Analysts from Swastika Investmart highlighted a significant 81% year-on-year revenue decline in FY24, questioning the valuation of approximately 6.8 times FY25 revenue for a non-profitable entity.

The IPO’s performance could set a precedent for other tech-driven insurance distributors, signaling that market sentiment is shifting towards clear profitability and sustainable growth models over pure scale.

👀 What to Watch Next

Investors should closely monitor the final subscription status as the IPO closes on June 23 to understand the overall demand for Turtlemint shares.

The company’s listing on June 29 will be a critical event, revealing how the market truly values the insurtech firm given its current financial metrics and the subdued GMP.

Future financial disclosures will be key to understanding how Turtlemint plans to address its revenue volatility and achieve profitability, which are crucial for long-term investor confidence.